Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

composite image showing powerpoint slide with qiang zhang photo and award information

Dr Qiang Zhang, deep learning scientist and a British Heart Foundation CRE fellow within OCMR and CVM, has won the Early Career Award (in the clinical category), at the Society for Cardiovascular Magnetic Resonance (SCMR) 25th Annual Scientific Sessions 2022

Dr Zhang received the award for his work titled “Development of Deep Learning Virtual Native Enhancement for Gadolinium-Free Myocardial Infarction and Viability Assessment”.

The current imaging gold-standard for detecting scar in the myocardium is a CMR scan that requires injection of a gadolinium-based contrast agent. Virtual Native Enhancement (VNE), invented by Dr Zhang with Prof. Stefan Piechnik, Prof. Vanessa Ferreira and their team, is a new artificial intelligence-based CMR technology for myocardial tissue characterisation that requires no gadolinium contrast and no needles.

 

I am very grateful for the fantastic mentorship and multi-disciplinary teamwork at OCMR which made this award possible. We aim to further develop AI solutions for faster and safer tests for heart conditions to improve patient care.
- Dr Qiang Zhang

 

VNE was previously validated in patients with hypertrophic cardiomyopathy, and has now been further developed for detecting scars from a previous heart attack (myocardial infarction). This new technique has enormous potential to replace conventional CMR scans for assessing other common cardiac pathologies. VNE can significantly reduce CMR scan time and costs, improve clinical practice, and expand the reach of CMR in the near future.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Enterprise Associate Interview with Dr Shilpa Nagarajan

Dr Shilpa Nagarajan is one of the MPLS Enterprise and Innovation Fellows for 2022-23.

The Gene Therapists Headline at Glastonbury 2022

Rosie Munday writes about her experience taking science to the masses at the Glastonbury Festival.

Intensive blood glucose control for people with type 2 diabetes when they are first diagnosed reduces diabetic complications and prolongs life

The study, which tracked volunteers for up to 44 years, showed that the benefits of early intensive blood glucose control can persist for decades.

Wellcome Trust funding success for Jim Hughes and James Davies

£3.6 million in funding awarded by the Wellcome Trust to combine cutting-edge 3D genome technologies with machine learning approaches to decipher the role of the non-coding genome in disease.

Study develops radiotranscriptomic AI analysis to enable virtual heart biopsies

RDM researchers tested the method in COVID-19 patients, to find that the results predicted in-hospital mortality.